Ratings and dated fundamentals
Exact eligible report scores in ranking order. Ratings summarize dated reports, not future returns; report and market dates remain in the table. Showing the first 10 of 500 recorded values; the complete table remains available below.
See the complete ratings and dated fundamentals
Scroll sideways to compare all columns. Select a heading to sort.
| 1 | ResMed Inc. | RMD | 4.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $235.3 | $33,096,608,806.3 | 20.77 | 5.56 |
| 2 | Arch Capital Group Ltd | ACGL | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $107.28 | $34,922,358,046.08 | 7.98 | 1.52 |
| 3 | Addus HomeCare Corp. | ADUS | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $124.31 | $2,316,307,511.96 | Not reported | 1.96 |
| 4 | Ametek, Inc. | AME | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $228.67 | $52,438,146,602.66 | 32.15 | 4.48 |
| 5 | Brown & Brown, Inc. | BRO | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $72.12 | $23,921,614,707.48 | 19.62 | Not reported |
| 6 | Chubb Limited | CB | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $365.02 | $139,466,557,614.44 | 12.42 | 1.78 |
| 7 | Corvel Corp | CRVL | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $83.16 | $4,186,741,093.92 | 34.45 | 9.73 |
| 8 | Exelixis Inc | EXEL | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $69.57 | $16,975,837,965.15 | 19.18 | 9.26 |
| 9 | First Mid Bancshares, Inc. Common Stock | FMBH | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $50.61 | $1,346,590,240.17 | 12.12 | 1.23 |
| 10 | Alphabet Inc. Class C Capital Stock | GOOG | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $283.93 | $3,490,635,420,000 | 14.81 | 5.15 |
| 11 | Alphabet Inc. Class A Common Stock | GOOGL | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $284.78 | $3,501,085,320,000 | 14.85 | 5.17 |
| 12 | The Hartford Insurance Group, Inc. | HIG | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $133.99 | $35,830,721,064.03 | 7.78 | 1.9 |
| 13 | Harmony Biosciences Holdings, Inc. Common Stock | HRMY | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $33.11 | $1,944,325,118.89 | 10.89 | 1.81 |
| 14 | Idexx Laboratories Inc | IDXX | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $676.04 | $53,262,666,590.6 | 45.05 | 28.5 |
| 15 | iRadimed Corporation | IRMD | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $86.31 | $1,103,745,485.43 | 46.02 | 10.37 |
| 16 | Intuitive Surgical Inc. | ISRG | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $452.8 | $156,960,275,510.4 | 53.08 | 9.74 |
| 17 | Neurocrine Biosciences Inc | NBIX | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $164.63 | $16,663,625,197.09 | 23.72 | 4.3 |
| 18 | UFP Technologies Inc | UFPT | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $303.47 | $2,350,977,841.42 | 30.72 | 4.84 |
| 19 | United Therapeutics Corp | UTHR | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $562.02 | $23,935,715,786.52 | 19.45 | 3.81 |
| 20 | ZOETIS INC. | ZTS | 4 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $79.4 | $32,261,502,071.8 | 12.98 | 9.77 |
| 21 | Agilent Technologies Inc. | A | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $174.76 | $49,269,886,525.04 | 34.22 | 6.69 |
| 22 | Acadia Pharmaceuticals Inc. | ACAD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $21.23 | $3,669,159,075.56 | 10.13 | 2.64 |
| 23 | ACNB Corp | ACNB | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $65.54 | $666,170,319.28 | 12.01 | 1.58 |
| 24 | ADMA Biologics, Inc. | ADMA | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $12.73 | $2,824,206,371.97 | 15.48 | 6.44 |
| 25 | Arthur J. Gallagher & Co. | AJG | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $281.61 | $72,204,804,000 | 42.47 | 3 |
| 26 | Alcon Inc. Ordinary Shares | ALC | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $74.94 | $36,225,996,000 | 36.97 | 1.64 |
| 27 | Align Technology Inc | ALGN | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $166 | $11,700,850,798 | 23.79 | 2.72 |
| 28 | Alkermes Inc. plc | ALKS | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $45.9 | $7,713,198,486 | Not reported | 4.14 |
| 29 | The Allstate Corporation | ALL | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $254.81 | $63,052,606,075.76 | 5.42 | 1.95 |
| 30 | Amphastar Pharmaceuticals, Inc. | AMPH | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $28.49 | $1,215,159,867.46 | 12.28 | 1.49 |
| 31 | Amazon.Com Inc | AMZN | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $259.3 | $2,803,846,762,745.8 | 20.8 | Not reported |
| 32 | argenx SE American Depositary Shares | ARGX | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $927.21 | $57,378,820,156.26 | 44.41 | 7.84 |
| 33 | AptarGroup, Inc. | ATR | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $142.5 | $9,032,929,650 | 33.81 | Not reported |
| 34 | Axis Capital Holders Limited | AXS | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $105.97 | $7,602,069,077.92 | 7.52 | 1.21 |
| 35 | AstraZeneca PLC | AZN | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $186.43 | $289,137,584,946.7 | 28.26 | 5.93 |
| 36 | Becton, Dickinson and Co. | BDX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $211.88 | $57,713,315,184 | 61.33 | Not reported |
| 37 | BioMarin Pharmaceuticals Inc | BMRN | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $56.03 | $10,852,715,946.02 | Not reported | 1.73 |
| 38 | Berkshire Hathaway Inc. | BRK-A | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $856,612 | $1,222,245,324,463.29 | 14.25 | 1.63 |
| 39 | BERKSHIRE HATHAWAY Class B | BRK-B | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $570.89 | $1,222,245,324,463.29 | 14.25 | 1.63 |
| 40 | Boston Scientific Corp. | BSX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $42.75 | $61,964,980,240.5 | 17.73 | Not reported |
| 41 | BWX Technologies, Inc. | BWXT | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $119.52 | $10,951,043,545.44 | 29.22 | 7.72 |
| 42 | Cardinal Health, Inc. | CAH | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $271.72 | $62,804,451,896.6 | 34.55 | Not reported |
| 43 | Cullen/Frost Bankers Inc. | CFR | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $155.23 | $9,652,282,895.75 | 14 | 2.43 |
| 44 | Chemed Corporation | CHE | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $528.05 | $6,872,525,865.75 | 24.34 | 7.98 |
| 45 | CNA Financial Corporation | CNA | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $47.32 | $12,805,473,076.76 | 12.43 | 1.25 |
| 46 | CONMED Corporation | CNMD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $51.5 | $1,534,871,134.5 | 20.9 | 1.45 |
| 47 | Corcept Therapeutics Inc. | CORT | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $72.77 | $7,964,175,041.93 | 49.07 | 9.55 |
| 48 | Quest Diagnostics Inc. | DGX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $255.63 | $28,124,175,630.99 | 24.91 | Not reported |
| 49 | DexCom, Inc. | DXCM | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $79.41 | $29,616,032,716.02 | 29.88 | 11.68 |
| 50 | Encompass Health Corporation Common Stock | EHC | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $137.54 | $13,495,921,732.02 | 20.94 | 3.79 |
| 51 | Electromed, Inc. | ELMD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $27.17 | $227,308,648.71 | 20.11 | 4.21 |
| 52 | The Ensign Group, Inc. | ENSG | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $181.08 | $10,564,327,799.28 | 26.47 | 4.12 |
| 53 | Edwards Lifesciences Corp | EW | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $102.14 | $58,730,500,000 | 57.51 | 5.36 |
| 54 | ExlService Holdings, Inc. | EXLS | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $43.15 | $6,506,533,742.65 | 24.97 | 7.01 |
| 55 | GENPACT LIMITED | G | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $42.27 | $7,068,685,120.92 | 12.01 | 2.61 |
| 56 | GE HealthCare Technologies Inc. Common Stock | GEHC | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $82.38 | $37,247,114,517.78 | 17.3 | 3.14 |
| 57 | GRAHAM HOLDINGS COMPANY | GHC | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1,212.02 | $5,132,817,434.56 | 10.39 | 1.06 |
| 58 | Gilead Sciences Inc | GILD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $166.89 | $207,000,111,290.46 | Not reported | Not reported |
| 59 | Globe Life Inc. | GL | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $157.18 | $11,857,617,704.48 | 10 | 1.79 |
| 60 | GLOBUS MEDICAL INC | GMED | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $71.05 | $9,539,308,989.7 | 17.11 | 1.99 |
| 61 | Gentex Corp | GNTX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $19.88 | $4,081,891,138.08 | 10.29 | 1.64 |
| 62 | Haemonetics Corporation | HAE | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $119.93 | $5,461,313,694.23 | 52.56 | Not reported |
| 63 | Halozyme Therapeutics, Inc. | HALO | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $103.63 | $11,814,856,300 | 24.34 | Not reported |
| 64 | HCA Healthcare, Inc. | HCA | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $494.99 | $103,399,698,575 | 15.26 | Not reported |
| 65 | Hamilton Insurance Group, Ltd. Class B Common Shares | HG | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $36.94 | $2,446,206,695.2 | 2.67 | 0.8 |
| 66 | HealthEquity, Inc | HQY | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $103.63 | $8,571,786,124.48 | 36.25 | 4.31 |
| 67 | Icon Plc | ICLR | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $204.74 | $15,338,450,071.76 | 66.88 | 1.67 |
| 68 | IDEX Corporation | IEX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $226.99 | $16,673,051,298.99 | 31.12 | 4.15 |
| 69 | Incyte Genomics Inc | INCY | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $119.65 | $24,388,557,667.8 | 60.46 | 4.32 |
| 70 | InMode Ltd. Ordinary Shares | INMD | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $13.33 | $767,063,812.76 | 8.17 | 1.12 |
| 71 | Jazz Pharmaceuticals, Inc. | JAZZ | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $234.76 | $15,069,021,847.52 | Not reported | Not reported |
| 72 | Johnson & Johnson | JNJ | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $276.22 | $664,947,241,674.52 | 41.31 | 8.16 |
| 73 | Krystal Biotech, Inc. Common Stock | KRYS | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $300.88 | $8,916,119,055.36 | 39.6 | 6.21 |
| 74 | Leidos Holdings, Inc. | LDOS | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $132.68 | $16,186,256,397.96 | 11.41 | 3.1 |
| 75 | LivaNova PLC Ordinary Shares | LIVN | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $89.99 | $4,957,261,941.91 | 25.28 | 3.61 |
| 76 | Eli Lilly & Co. | LLY | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1,354 | $1,273,768,771,974 | 46.19 | 31.63 |
| 77 | LeMaitre Vascular, Inc. | LMAT | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $80.89 | $1,850,833,655.19 | 29.22 | 4.28 |
| 78 | McKesson Corporation | MCK | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1,060.84 | $122,481,047,437.76 | 26.06 | Not reported |
| 79 | Medtronic plc | MDT | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $101.8 | $130,216,237,202 | 24.89 | 2.56 |
| 80 | MiMedx Group, Inc | MDXG | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.31 | $483,013,706.21 | Not reported | 2.29 |
| 81 | Medpace Holdings, Inc. Common Stock | MEDP | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $653.11 | $18,268,587,843.46 | 35.28 | 31.23 |
| 82 | Markel Group Inc. | MKL | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1,939.04 | $23,713,227,909.6 | 13.23 | 1.25 |
| 83 | MAXIMUS, Inc. | MMS | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $65.5 | $3,429,433,476.5 | 9.25 | 1.97 |
| 84 | Merit Medical Systems Inc | MMSI | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $87.23 | $5,226,389,288.12 | 32.64 | 3 |
| 85 | Merck & Co., Inc. | MRK | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $146.73 | $361,725,499,800.24 | 147.46 | Not reported |
| 86 | Nordson Corp | NDSN | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $309.86 | $17,259,005,548.76 | 31.09 | Not reported |
| 87 | Novo-Nordisk A/S | NVO | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $40.31 | $179,137,640,000 | 11.55 | 5.88 |
| 88 | OSI Systems Inc | OSIS | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $196.36 | $3,088,380,712.16 | 19.46 | 3.95 |
| 89 | OneSpaWorld Holdings Limited Common Shares | OSW | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $31.13 | $3,116,265,786.04 | 36.73 | 5.46 |
| 90 | Paychex Inc | PAYX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $117.06 | $41,671,074,169.38 | 23.07 | 11.25 |
| 91 | Prestige Consumer Healthcare Inc. | PBH | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $42.98 | $2,037,127,615.88 | 13.13 | 1.05 |
| 92 | PUMA BIOTECHNOLOGY INC | PBYI | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.25 | $425,865,544.5 | 15.94 | 3.07 |
| 93 | Peoples Bancorp Inc/OH | PEBO | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $38.6 | $1,388,040,907.4 | 11.44 | 1.13 |
| 94 | Procter & Gamble Company | PG | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $165.4 | $383,361,331,852.2 | 23.92 | 6.93 |
| 95 | Insulet Corporation | PODD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $146.51 | $10,163,551,509.93 | 23.7 | 6.44 |
| 96 | Dr. Reddy's Laboratories Limited American Depositary Shares | RDY | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $14.91 | $12,444,735,422.7 | 27.53 | 3.07 |
| 97 | Regeneron Pharmaceuticals Inc | REGN | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $904.35 | $93,553,071,286.65 | 19.42 | 2.79 |
| 98 | Roper Technologies, Inc. Common Stock | ROP | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $476.6 | $47,200,762,061.4 | 18.22 | 2.46 |
| 99 | Skyward Specialty Insurance Group, Inc. Common Stock | SKWD | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $60.35 | $2,680,351,647.15 | 13.98 | 2.1 |
| 100 | SmartFinancial, Inc. | SMBK | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $47.73 | $816,110,116.29 | 14.22 | 1.41 |
| 101 | 1st Source Corp | SRCE | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $86.94 | $2,093,942,857.86 | 11.75 | 1.55 |
| 102 | SS&C Technologies Inc | SSNC | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $77.71 | $18,235,039,739.16 | 21.11 | 2.72 |
| 103 | STERIS plc | STE | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $252.3 | $24,500,101,146 | 29.63 | 3.37 |
| 104 | Stryker Corporation | SYK | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $325.87 | $124,055,777,473.48 | 34.24 | 5.29 |
| 105 | Tactile Systems Technology, Inc. | TCMD | 3.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $26.03 | $583,107,739.19 | 24.48 | 2.57 |
| 106 | TE Connectivity plc | TEL | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $207.01 | $59,932,133,328.28 | 19.87 | 4.47 |
| 107 | Thermo Fisher Scientific, Inc. | TMO | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $694.76 | $257,419,604,451.68 | 36.42 | Not reported |
| 108 | Universal Health Services, Inc. Class B | UHS | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $195.5 | $11,522,088,682.5 | 7.55 | Not reported |
| 109 | Veracyte, Inc. | VCYT | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $24.16 | $1,949,602,796.8 | 15.37 | 1.36 |
| 110 | Village Super Market | VLGEA | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $41.22 | $440,282,485.26 | 8.39 | 0.84 |
| 111 | Vertex Pharmaceuticals Inc | VRTX | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $547.09 | $138,707,926,068.66 | 34.89 | 6.63 |
| 112 | Waters Corp | WAT | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $457.6 | $44,958,335,593.6 | 270.61 | 2.96 |
| 113 | W.R. Berkley Corporation | WRB | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $75.23 | $27,949,131,828.48 | 15 | 2.91 |
| 114 | West Pharmaceutical Services, Inc. | WST | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $399.81 | $27,851,178,803.16 | 43.59 | 9.38 |
| 115 | Zimmer Biomet Holdings, Inc. | ZBH | 3.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $105.59 | $19,983,318,033.92 | 26.04 | 1.57 |
| 116 | ABBVIE INC. | ABBV | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $291.31 | $514,924,306,100.86 | 49.79 | Not reported |
| 117 | Abbott Laboratories | ABT | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $109.93 | $190,392,340,197.93 | 40.5 | Not reported |
| 118 | Acme United Corporation | ACU | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $68.38 | $262,156,816.74 | 26.71 | 2.16 |
| 119 | Aflac Inc. | AFL | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $124.06 | $61,360,951,863.6 | 17.4 | 2.1 |
| 120 | American Healthcare REIT, Inc. | AHR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $57.91 | $12,624,309,060.25 | 104.32 | 3.37 |
| 121 | Amgen Inc | AMGN | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $460.42 | $249,046,468,225.8 | 26.52 | Not reported |
| 122 | ANI Pharmaceuticals, Inc. | ANIP | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $67.41 | $1,548,431,428.32 | 13.25 | 2.43 |
| 123 | Aon plc Class A | AON | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $334.81 | $71,032,344,096.56 | 18.07 | 6.95 |
| 124 | Ardent Health, Inc. | ARDT | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $17.3 | $2,438,199,598.9 | 16.67 | 1.37 |
| 125 | Arrow Financial Corp | AROW | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $38.47 | $712,607,623.81 | 13.9 | 1.6 |
| 126 | Aurinia Pharmaceuticals Inc | AUPH | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $16.46 | $2,205,617,943.6 | 7.02 | 3.35 |
| 127 | Biogen Inc. Common Stock | BIIB | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $248.35 | $36,711,152,382.05 | 105.64 | 1.94 |
| 128 | BillionToOne, Inc. Class A Common Stock | BLLN | 3 | 2026-10-14 | 2026 IPO | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $113.94 | $5,376,491,109.72 | 108.85 | 9.49 |
| 129 | Bank of Montreal | BMO | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $171.13 | $118,951,134,517.81 | 19.04 | 1.89 |
| 130 | Bristol-Myers Squibb Co. | BMY | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $62.14 | $127,019,493,538.34 | 13.74 | 5.43 |
| 131 | CareCloud, Inc. Common Stock | CCLD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.3 | $97,862,375.7 | 10.13 | 4.33 |
| 132 | CareDx, Inc. | CDNA | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $78.56 | $4,127,761,268.16 | 32.09 | 8.83 |
| 133 | Church & Dwight Co., Inc. | CHD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $109.33 | $25,805,384,245.16 | 33.31 | 5.75 |
| 134 | Chewy, Inc. | CHWY | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $22.56 | $9,236,610,109.92 | 33.75 | 24.93 |
| 135 | The Cigna Group | CI | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $293.59 | $77,361,716,883.99 | 13.57 | 1.77 |
| 136 | CNO Financial Group, Inc. | CNO | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $55.45 | $5,065,321,956.55 | 11.91 | 2.18 |
| 137 | Coherent Corp. | COHR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $192.81 | $37,975,600,969.89 | 39.42 | 3.26 |
| 138 | Collegium Pharmaceutical, Inc. Common Stock | COLL | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $24.21 | $752,336,015.04 | 19.71 | 2.54 |
| 139 | Concentra Group Holdings Parent, Inc. | CON | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $42.22 | $5,341,578,813.92 | 24.69 | 9.95 |
| 140 | The Cooper Companies, Inc. Common Stock | COO | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $62.36 | $11,858,084,133.84 | 20.79 | 1.42 |
| 141 | Cencora, Inc. | COR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $333.56 | $63,652,309,157.4 | 24.25 | Not reported |
| 142 | Castle Biosciences, Inc. Common Stock | CSTL | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $32.52 | $1,002,210,823.32 | Not reported | 2.09 |
| 143 | Danaher Corporation | DHR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $230.25 | $161,987,970,153.75 | 37.4 | Not reported |
| 144 | Deswell Industries Inc | DSWL | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $3.04 | $48,291,126.56 | 4.54 | 0.44 |
| 145 | DaVita Inc. | DVA | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $191.35 | $12,035,915,000 | 13.08 | 10.69 |
| 146 | Everest Group, Ltd. | EG | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $411.11 | $15,228,746,085.56 | 8.05 | 1.07 |
| 147 | Elanco Animal Health Incorporated Common Stock | ELAN | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.74 | $12,865,548,704.58 | Not reported | 1.94 |
| 148 | Flex Ltd. Ordinary Shares | FLEX | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $69.78 | $25,779,127,599.1 | 24.86 | 4.44 |
| 149 | Fortive Corporation | FTV | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $65.37 | $19,457,018,088.72 | 29.85 | Not reported |
| 150 | H.B. Fuller Company | FUL | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $49.86 | $2,683,919,873.34 | 13.57 | 1.24 |
| 151 | Guardian Pharmacy Services, Inc. | GRDN | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $42.39 | $2,110,975,540.56 | 28.23 | 7.55 |
| 152 | GSK plc American Depositary Shares (Each representing two Ordinary Shares) | GSK | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $50.33 | $108,598,174,079.29 | 13.09 | 5.06 |
| 153 | Hamilton Beach Brands Holding Company Class A Common Stock | HBB | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $32.16 | $432,305,397.12 | 7.29 | 1.96 |
| 154 | Hims & Hers Health, Inc. | HIMS | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $26 | $6,066,148,738 | Not reported | 18.72 |
| 155 | Haleon plc American Depositary Shares (Each representing two Ordinary Shares) | HLN | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $9.14 | $40,912,256,171.36 | 18.47 | 1.85 |
| 156 | Horace Mann Educators Corporation | HMN | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $53.25 | $2,157,623,011.5 | 12.16 | 1.52 |
| 157 | Hinge Health, Inc. | HNGE | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $115.76 | $9,341,185,711.92 | 85.64 | 27.13 |
| 158 | Henry Schein Inc | HSIC | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $86.05 | $9,511,841,539.1 | 22.59 | 2.01 |
| 159 | Immunocore Holdings plc American Depositary Shares | IMCR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $30.99 | $1,601,605,842.24 | Not reported | 3.82 |
| 160 | InfuSystem Holdings, Inc. | INFU | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.69 | $272,666,207.89 | 31.92 | 4.61 |
| 161 | Inspire Medical Systems, Inc. | INSP | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $63.98 | $1,853,252,293.62 | 18.4 | 2.24 |
| 162 | IQVIA Holdings Inc. | IQV | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $271.83 | $44,797,584,000 | 32.14 | 6.6 |
| 163 | Integer Holdings Corporation | ITGR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $126.56 | $4,302,702,970.72 | 41.49 | 2.49 |
| 164 | ORIX Corporation American Depositary Shares (each representing One (1) Share of Common Stock) | IX | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $34.85 | $39,175,115,846.4 | 13.19 | 1.34 |
| 165 | Jabil Inc. | JBL | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $239.09 | $24,620,166,032.3 | 23.63 | 15.23 |
| 166 | JD.com, Inc. | JD | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $29.11 | $39,999,086,454.71 | 12.09 | 0.95 |
| 167 | KB Financial Group Inc | KB | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $111.2 | $37,856,343,957.07 | 9.36 | 0.9 |
| 168 | Kimball Electronics, Inc. | KE | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $19.26 | $461,782,401.66 | 22.51 | 0.79 |
| 169 | Kamada Ltd | KMDA | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $7.23 | $417,245,505.15 | 20.66 | Not reported |
| 170 | Kiniksa Pharmaceuticals International, plc Class A Ordinary Shares | KNSA | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $93.86 | $7,323,333,860.18 | 66.84 | 10.31 |
| 171 | LifeStance Health Group, Inc. Common Stock | LFST | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.77 | $5,235,226,269.48 | 72.8 | 3.51 |
| 172 | Labcorp Holdings Inc. | LH | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $366.57 | $29,765,484,000 | 29.65 | 3.36 |
| 173 | Lantheus Holdings, Inc | LNTH | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $100.61 | $6,580,036,161.93 | 24.38 | 4.85 |
| 174 | Luxfer Holdings PLC Ordinary Shares | LXFR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $17.32 | $463,478,194.52 | 74.75 | 2.09 |
| 175 | MetLife, Inc. | MET | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $98.27 | $62,448,317,616.29 | 17.22 | 2.23 |
| 176 | Mirion Technologies, Inc. | MIR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $17.97 | $4,475,206,516.59 | 154.32 | 2.44 |
| 177 | Mesa Laboratories Inc | MLAB | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $128.25 | $717,670,199.25 | 149.51 | 3.8 |
| 178 | Mannkind Corporation | MNKD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.9 | $1,254,396,460.2 | Not reported | Not reported |
| 179 | Materialise NV | MTLS | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $6.75 | $398,703,505.5 | 45.72 | Not reported |
| 180 | Novanta Inc. Common Stock | NOVT | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $135.15 | $5,111,071,615.5 | 82.75 | 3.16 |
| 181 | Nutex Health Inc. Common Stock | NUTX | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $180.56 | $1,238,784,964.64 | 7.52 | 2.29 |
| 182 | Novartis AG | NVS | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $162.55 | $310,170,055,421.45 | 22.21 | 6.66 |
| 183 | Omada Health, Inc. Common Stock | OMDA | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $15.09 | $923,760,048.27 | 214.58 | 3.65 |
| 184 | PACS Group, Inc. | PACS | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $49.6 | $7,872,687,236.8 | 28.36 | 6.46 |
| 185 | Phibro Animal Health Corporation Class A | PAHC | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $32.96 | $1,338,228,834.88 | 13.03 | 3.2 |
| 186 | Pioneer Bancorp, Inc. Common Stock | PBFS | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $18.35 | $455,844,516.05 | 27.06 | 1.39 |
| 187 | Pro-Dex Inc New | PDEX | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $63.16 | $202,096,063.16 | 16.8 | 4.1 |
| 188 | Penumbra, Inc. | PEN | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $319.21 | $12,581,465,835.85 | 80.13 | 7.95 |
| 189 | Pfizer Inc. | PFE | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $29.39 | $167,518,701,212.87 | 41.53 | 1.88 |
| 190 | Principal Financial Group, Inc. | PFG | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $110.91 | $23,554,673,954.97 | 11.91 | 1.92 |
| 191 | Progyny, Inc. Common Stock | PGNY | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $34.84 | $2,565,873,116.56 | 28.19 | 6.2 |
| 192 | Philip Morris International Inc. | PM | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $197.88 | $308,426,775,866.52 | 28.8 | Not reported |
| 193 | The Pennant Group, Inc. Common Stock | PNTG | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $36.36 | $1,277,412,755.04 | 35.61 | 3.04 |
| 194 | Prudential Financial, Inc. | PRU | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $119.24 | $40,899,320,000 | 10.55 | 1.26 |
| 195 | Privia Health Group, Inc. Common Stock | PRVA | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $24.42 | $3,120,101,544.12 | 89.79 | 3.57 |
| 196 | Pricesmart Inc | PSMT | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $162.46 | $5,024,599,758.42 | 30.16 | 3.45 |
| 197 | Pearson plc | PSO | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $17.27 | $10,386,165,738.3 | 23.44 | 2.11 |
| 198 | RadNet, Inc. Common Stock | RDNT | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $76 | $5,980,991,532 | Not reported | 4.29 |
| 199 | Reinsurance Group of America, Incorporated | RGA | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $261.9 | $17,102,506,063.5 | 11.34 | 1.24 |
| 200 | Rigel Pharmaceuticals Inc. (New) | RIGL | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $39.65 | $746,608,389.8 | 2.43 | 1.68 |
| 201 | Revvity, Inc. | RVTY | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $155.11 | $17,308,166,659.11 | 72.86 | 2.39 |
| 202 | Ryan Specialty Holdings, Inc. | RYAN | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $47.73 | $5,713,000,108.95 | 54.61 | 6.34 |
| 203 | Sabra Healthcare REIT, Inc. | SBRA | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $21.02 | $5,506,429,910.22 | 77 | 1.94 |
| 204 | Shinhan Financial Group Co Ltd | SHG | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $63.52 | $28,262,423,780.92 | 7.89 | 0.68 |
| 205 | SIGA Technologies Inc. | SIGA | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.1 | $222,734,119.6 | Not reported | 1.35 |
| 206 | Smith & Nephew plc | SNN | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $31.15 | $13,670,564,460.88 | 21.87 | 2.58 |
| 207 | Sanofi American Depositary Shares (Each representing one-half of one ordinary share) | SNY | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $47.04 | $114,723,701,191.68 | 12.93 | Not reported |
| 208 | SiriusPoint Ltd. | SPNT | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $26.33 | $3,028,794,139.8 | 6.04 | 1.36 |
| 209 | StoneCo Ltd. Class A Common Shares | STNE | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $7.51 | $1,731,773,196.32 | 4.13 | 0.87 |
| 210 | Stevanato Group S.p.A. | STVN | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $13.57 | $3,706,356,011.19 | 23.45 | 2.13 |
| 211 | Standex International Corporation | SXI | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $228.36 | $2,764,003,215.6 | 24.3 | 3.55 |
| 212 | Toronto Dominion Bank | TD | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $122.4 | $199,881,247,262.4 | 13.59 | 2.19 |
| 213 | Bio-Techne Corp. | TECH | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $72.78 | $11,430,503,947.92 | 62.85 | Not reported |
| 214 | Tenet Healthcare Corporation New | THC | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $283.33 | $22,549,668,040 | 5.91 | 2.35 |
| 215 | Gentherm Inc | THRM | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $29.47 | $1,547,307,968.64 | 171.26 | 2.15 |
| 216 | Telix Pharmaceuticals Limited American Depositary Shares | TLX | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $9.63 | $3,262,422,981.87 | Not reported | 7.85 |
| 217 | TransMedics Group, Inc. Common Stock | TMDX | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $88.24 | $3,064,917,835.92 | 21.22 | 5.57 |
| 218 | UNITEDHEALTH GROUP INCORPORATED (Delaware) | UNH | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $394.15 | $353,167,312,125.65 | 22.23 | 3.35 |
| 219 | Unum Group | UNM | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $76.75 | $11,894,870,802.5 | 48.89 | 1.11 |
| 220 | US Physical Therapy Inc | USPH | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $99.49 | $1,485,232,584.89 | 49.29 | 1.89 |
| 221 | Utah Medical Products Inc | UTMD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $72.23 | $229,967,174.14 | 21.93 | 1.88 |
| 222 | Vericel Corporation | VCEL | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $54.62 | $2,787,246,037.4 | 83.68 | 7.26 |
| 223 | Viemed Healthcare, Inc. Common Shares | VMD | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.13 | $345,963,948.22 | 22.14 | 2.28 |
| 224 | VOYA FINANCIAL, INC. | VOYA | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $99.01 | $8,843,562,110.88 | 14.15 | 1.51 |
| 225 | Ventas, Inc. | VTR | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $88.75 | $46,932,775,000 | 172.84 | 2.87 |
| 226 | Waterdrop Inc. American Depositary Shares (each representing the right to receive 10 Class A Ordinary Shares) | WDH | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.01 | $364,492,326.92 | 4.51 | 0.49 |
| 227 | Welltower Inc. | WELL | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $245.01 | $179,741,752,533.63 | 102.83 | 3.6 |
| 228 | Walmart Inc. Common Stock | WMT | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $125.52 | $995,843,828,170.32 | 45.11 | Not reported |
| 229 | White Mountains Insurance Group Ltd. | WTM | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2,241.12 | $5,349,156,761.76 | 5.52 | 0.86 |
| 230 | Willis Towers Watson Public Limited Company Ordinary Shares | WTW | 3 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $328.86 | $30,326,230,055.52 | 19.39 | 3.87 |
| 231 | XP Inc. Class A Common Stock | XP | 3 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $15.14 | $7,682,686,702.06 | 8.3 | 1.8 |
| 232 | Atlantic American Corp | AAME | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.11 | $22,640,923.08 | 3.76 | 0.19 |
| 233 | Aurora Cannabis Inc. Common Shares | ACB | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $5.24 | $331,744,719.64 | Not reported | 0.9 |
| 234 | Acadia Healthcare Company, Inc. | ACHC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $37 | $3,439,767,345 | Not reported | 1.53 |
| 235 | Albertsons Companies, Inc. | ACI | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $12.79 | $6,017,470,190.17 | Not reported | Not reported |
| 236 | Adaptive Biotechnologies Corporation Common Stock | ADPT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $27.98 | $4,529,309,898.12 | Not reported | 24.63 |
| 237 | AdaptHealth Corp. Common Stock | AHCO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.33 | $1,000,730,800.84 | Not reported | 0.81 |
| 238 | American International Group, Inc. | AIG | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $77.75 | $40,308,622,764.5 | 12.23 | 1.04 |
| 239 | Akebia Therapeutics, Inc. | AKBA | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.4 | $111,426,513.04 | Not reported | 5.47 |
| 240 | Alignment Healthcare, Inc. Common Stock | ALHC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.34 | $1,536,030,011.96 | 53.12 | 5.54 |
| 241 | Alnylam Pharmaceuticals, Inc. | ALNY | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $155.94 | $20,886,225,601.44 | 7.67 | 5.8 |
| 242 | AMN Healthcare Services | AMN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $36.19 | $1,401,638,374.29 | 13.36 | 1.89 |
| 243 | Amneal Pharmaceuticals, Inc. Class A Common Stock | AMRX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $20.14 | $6,431,787,928.66 | 40.87 | 54.98 |
| 244 | Artivion, Inc. | AORT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $20.21 | $986,041,292.12 | Not reported | 2.21 |
| 245 | Ardelyx, Inc. | ARDX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.88 | $723,952,952.64 | Not reported | 4.41 |
| 246 | Arcutis Biotherapeutics, Inc. Common Stock | ARQT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.55 | $3,230,926,093.15 | 108.02 | 13.24 |
| 247 | Arrowhead Research Corporation | ARWR | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $58.16 | $8,215,359,800.72 | Not reported | 17.63 |
| 248 | Astrana Health Inc. Common Stock | ASTH | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $34.5 | $1,925,102,173.5 | 36.24 | 3.05 |
| 249 | AtriCure, Inc. | ATRC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $58.54 | $2,980,990,446.82 | 200.29 | 5.59 |
| 250 | Aveanna Healthcare Holdings Inc. Common Stock | AVAH | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.25 | $2,891,410,972 | 10.52 | 10.04 |
| 251 | Avalon Holdings Corp. | AWX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.55 | $9,943,549.05 | 8.32 | Not reported |
| 252 | Axogen, Inc. Common Stock | AXGN | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $50.02 | $2,987,730,364.3 | Not reported | 6.02 |
| 253 | Credicorp LTD | BAP | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $347.93 | $27,632,362,963.81 | 13.81 | 2.33 |
| 254 | Banco Bradesco S.A. American Depositary Shares (Each representing one Preferred Shares) | BBD | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $2.54 | $26,164,071,658.14 | 6.1 | 0.81 |
| 255 | Banco Bradesco S.A. American Depositary Shares (Each representing one Common Share, no par value) | BBDO | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $2.4 | $26,164,071,658.14 | 6.1 | 0.81 |
| 256 | BridgeBio Oncology Therapeutics, Inc. Common Stock | BBOT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.04 | $163,555,504.68 | Not reported | 0.51 |
| 257 | BioCryst Pharmaceuticals Inc | BCRX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.69 | $1,978,631,378.61 | Not reported | Not reported |
| 258 | Baird Medical Investment Holdings Ltd Ordinary Share | BDMD | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.09 | $2,825,894.72 | Not reported | 0.09 |
| 259 | Bio-Rad Laboratories, Inc.Class A | BIO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $381.57 | $10,202,485,434.75 | 9.97 | 1.34 |
| 260 | Bausch + Lomb Corporation | BLCO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $19.99 | $7,146,372,506.26 | Not reported | 1.1 |
| 261 | Brookfield Corporation | BN | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $41.38 | $92,374,703,042.38 | 28.55 | 0.56 |
| 262 | Bruker Corporation | BRKR | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $61.31 | $9,363,376,316.95 | Not reported | Not reported |
| 263 | Biote Corp. Class A Common Stock | BTMD | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.06 | $38,083,116.08 | 6.5 | Not reported |
| 264 | BrightSpring Health Services, Inc. Common Stock | BTSG | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $67.15 | $13,361,816,695.8 | 32.57 | 6.11 |
| 265 | Bioventus Inc. Class A Common Stock | BVS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.61 | $892,214,846.8 | 15.57 | 3.06 |
| 266 | The Baldwin Insurance Group, Inc. Class A Common Stock | BWIN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $31.98 | $3,096,897,532.56 | Not reported | 2.18 |
| 267 | Caris Life Sciences, Inc. Common Stock | CAI | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.23 | $7,235,573,035.92 | 75.32 | 11.31 |
| 268 | Carlsmed, Inc. Common Stock | CARL | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $14.52 | $396,435,828.36 | Not reported | 4.71 |
| 269 | Clover Health Investments, Corp | CLOV | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.82 | $2,560,173,187.66 | 205.64 | 6.55 |
| 270 | Centene Corporation | CNC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $69.74 | $34,526,042,320 | 23.65 | 1.55 |
| 271 | CorMedix Inc. | CRMD | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.32 | $414,663,803.68 | 2.22 | 0.9 |
| 272 | Cronos Group Inc. Common Share | CRON | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.61 | $1,322,961,389.39 | 22.88 | 1.18 |
| 273 | Cytek Biosciences, Inc. Common Stock | CTKB | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.83 | $762,470,527.61 | Not reported | 2.37 |
| 274 | CVS HEALTH CORPORATION | CVS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $83.85 | $107,283,910,663.8 | 9.72 | 1.33 |
| 275 | DocGo Inc. Common Stock | DCGO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.25 | $24,237,450.41 | Not reported | 0.25 |
| 276 | Delcath Systems Inc | DCTH | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $14.93 | $518,053,009.35 | 973.78 | 4.28 |
| 277 | DuPont de Nemours, Inc. Common Stock | DD | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $146.52 | $19,418,638,163.76 | 64.51 | 1.42 |
| 278 | DLH Holdings Corp. | DLHC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.61 | $52,319,856.35 | Not reported | 0.56 |
| 279 | Elevance Health, Inc. | ELV | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $425.62 | $91,957,708,327.42 | 17.89 | 2.05 |
| 280 | Enliven Therapeutics, Inc. Common Stock | ELVN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $49.43 | $3,637,807,374.76 | Not reported | 4.15 |
| 281 | Embecta Corp. Common Stock | EMBC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.19 | $350,722,917.81 | 4.01 | Not reported |
| 282 | Equitable Holdings, Inc. | EQH | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $52.66 | $14,043,227,302.58 | Not reported | 57.55 |
| 283 | Eton Pharmaceutcials, Inc. Common Stock | ETON | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $56.46 | $1,628,431,458.9 | 32.66 | 18.73 |
| 284 | National Vision Holdings, Inc. Common Stock | EYE | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $17.9 | $1,415,340,702.7 | 28.15 | 1.58 |
| 285 | Fulgent Genetics, Inc. Common Stock | FLGT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $23.74 | $663,271,860 | Not reported | 0.67 |
| 286 | Fresenius Medical Care AG | FMS | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $23.4 | $11,477,216,368.8 | 8.52 | 0.68 |
| 287 | FOMENTO ECONOMICO MEXICANO, S.A.B. DE C.V. | FMX | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $129.85 | $44,567,552,192.28 | 24.27 | 2.44 |
| 288 | Freedom Holding Corp. | FRHC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $178.85 | $11,408,424,064.1 | 73.8 | 7.43 |
| 289 | GoodRx Holdings, Inc. Class A Common Stock | GDRX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.51 | $1,197,420,311.88 | 73.69 | 1.85 |
| 290 | Glaukos Corporation | GKOS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $224.41 | $13,284,369,596.7 | Not reported | 18.52 |
| 291 | Monte Rosa Therapeutics, Inc. Common Stock | GLUE | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.57 | $903,207,757.83 | Not reported | 1.82 |
| 292 | Genworth Financial, Inc. | GNW | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.7 | $3,186,026,025.6 | 57.93 | 0.33 |
| 293 | Gyre Therapeutics, Inc. Common Stock | GYRE | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $4.76 | $530,786,881.24 | Not reported | 3.22 |
| 294 | HUTCHMED (China) Limited American Depositary Shares | HCM | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $15.16 | $2,644,897,343.84 | 5.79 | 2.11 |
| 295 | Health In Tech, Inc. Class A Common Stock | HIT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.56 | $36,529,018.37 | Not reported | 1.86 |
| 296 | The Honest Company, Inc. Common Stock | HNST | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.67 | $509,425,628.39 | 6.5 | 1.94 |
| 297 | Humana Inc. | HUM | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $433.74 | $52,093,583,655 | 41.81 | 2.76 |
| 298 | Integra LifeSciences Holdings | IART | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.42 | $1,044,089,097.92 | 80.23 | 0.98 |
| 299 | ICU Medical Inc | ICUI | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $172.11 | $4,304,488,138.89 | 71.35 | Not reported |
| 300 | Illumina Inc | ILMN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $213.13 | $32,225,256,000 | 36.01 | Not reported |
| 301 | Ingles Markets Inc | IMKTA | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $82.25 | $1,196,974,873.5 | 11.51 | 0.71 |
| 302 | Immatics N.V. Ordinary Shares | IMTX | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $6.36 | $968,151,489.72 | Not reported | Not reported |
| 303 | Innoviva, Inc. Common Stock | INVA | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $19.1 | $1,357,656,210.7 | Not reported | Not reported |
| 304 | IPG Photonics Corporation | IPGP | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $65.31 | $2,776,206,623.4 | Not reported | 1.29 |
| 305 | iRhythm Holdings, Inc. Common Stock | IRTC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $90.22 | $3,033,029,132.12 | Not reported | 17.13 |
| 306 | Ironwood Pharmaceuticals, Inc. - Class A | IRWD | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.39 | $726,767,836.4 | 4.86 | Not reported |
| 307 | Kiora Pharmaceuticals, Inc. Common Stock | KPRX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.44 | $6,371,117.28 | Not reported | 0.38 |
| 308 | The Kroger Co. | KR | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $67.7 | $39,982,854,990 | 36.85 | 6.84 |
| 309 | Keros Therapeutics, Inc. Common Stock | KROS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.36 | $183,684,140.64 | Not reported | 0.66 |
| 310 | Legend Biotech Corporation American Depositary Shares | LEGN | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $23.4 | $4,327,670,517.3 | Not reported | 4.32 |
| 311 | Ligand Pharmaceuticals Inc. | LGND | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $306.2 | $6,124,914,313.2 | 119.02 | 6.37 |
| 312 | Lincoln National Corp. | LNC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $40.05 | $7,626,443,793.3 | 2.3 | 0.81 |
| 313 | Maze Therapeutics, Inc. Common Stock | MAZE | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $34.19 | $1,899,226,053.92 | Not reported | 4.19 |
| 314 | Pediatrix Medical Group, Inc. | MD | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $31.29 | $2,444,522,363.64 | 16.29 | 2.88 |
| 315 | Medline Inc. Class A common stock | MDLN | 2.5 | 2026-10-14 | 2026 IPO | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $39.64 | $34,778,202,281.52 | Not reported | 1.79 |
| 316 | Manulife Financial Corp. | MFC | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $43.24 | $71,430,741,665.52 | 16.46 | 1.87 |
| 317 | Mirum Pharmaceuticals, Inc. Common Stock | MIRM | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $93.72 | $6,118,233,163.68 | Not reported | Not reported |
| 318 | 3M Company | MMM | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $185.15 | $95,672,480,626.1 | 27.06 | 18.61 |
| 319 | Molina Healthcare, Inc. | MOH | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $208.99 | $10,909,278,000 | Not reported | 2.63 |
| 320 | NeoGenomics, Inc. | NEO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $16.84 | $2,178,918,590.6 | Not reported | 2.72 |
| 321 | Nephros Inc. | NEPH | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.79 | $30,327,311.16 | Not reported | 2.42 |
| 322 | Neuphoria Therapeutics Inc. Common Stock | NEUP | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.78 | $83,575.05 | Not reported | 0 |
| 323 | Anbio Biotechnology Class A Ordinary Shares | NNNN | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $3.89 | $170,736,768 | 26.66 | 5.66 |
| 324 | Neuropace, Inc. Common Stock | NPCE | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $12.5 | $429,053,425 | Not reported | 36.11 |
| 325 | Insperity, Inc | NSP | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $49.82 | $1,897,948,000.92 | 632.65 | 43.14 |
| 326 | Natera, Inc. Common Stock | NTRA | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $310.67 | $45,048,554,539.07 | Not reported | 24.1 |
| 327 | Envista Holdings Corporation Common stock, $0.01 par value per share | NVST | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.17 | $4,035,882,089.46 | 6.37 | Not reported |
| 328 | Organigram Global Inc. Common Shares | OGI | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.88 | $126,364,249.81 | Not reported | 0.5 |
| 329 | Organon & Co. | OGN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $13.87 | $3,642,561,370.08 | 17.1 | 3.05 |
| 330 | Omnicell Inc | OMCL | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $37.34 | $1,717,454,569.56 | 38.45 | 1.3 |
| 331 | BeOne Medicines Ltd. American Depositary Shares | ONC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $406.96 | $46,485,445,235.06 | 50.77 | 7.99 |
| 332 | Organogenesis Holdings Inc. Class A Common Stock | ORGO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.81 | $105,554,758.7 | Not reported | 0.4 |
| 333 | Oramed Pharmaceuticals Inc. | ORMP | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.86 | $160,565,786.44 | 0.92 | 0.51 |
| 334 | Oscar Health, Inc. | OSCR | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $30.65 | $9,459,969,250 | 11.06 | 4.25 |
| 335 | Pacira BioSciences, Inc. Common Stock | PCRX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $36.43 | $1,460,648,463.8 | 38.72 | 2.05 |
| 336 | PhenixFIN Corporation Common Stock | PFX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $42.03 | $81,161,747.83 | 17.37 | 0.51 |
| 337 | Pharming Group N.V. ADS, each representing 10 ordinary shares | PHAR | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $12.29 | $869,863,143.96 | 342.74 | Not reported |
| 338 | KONINKLIJKE PHILIPS N.V. | PHG | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $30.35 | $29,670,584,900 | 29.27 | 2.3 |
| 339 | Protalix BioTherapeutics, Inc. Common Stock | PLX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.54 | $204,651,970.68 | 10.8 | 2.87 |
| 340 | PROCEPT BioRobotics Corporation Common Stock | PRCT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $20.62 | $1,186,394,815.02 | Not reported | 3.61 |
| 341 | Precipio, Inc. Common Stock | PRPO | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $18.62 | $33,333,300.56 | Not reported | 2.26 |
| 342 | PTC Therapeutics, Inc. | PTCT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $65.44 | $5,467,137,944.96 | Not reported | Not reported |
| 343 | Protagonist Therapeutics, Inc | PTGX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $132.04 | $8,618,265,852.56 | 25.18 | 7.94 |
| 344 | PRUDENTIAL PLC ADS (REP 2 ORD SHARES) | PUK | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $24.76 | $31,546,886,584.02 | 7.66 | 1.48 |
| 345 | QIAGEN N.V. | QGEN | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $50.33 | $10,392,969,901.93 | 24.46 | 2.75 |
| 346 | RCM Technologies Inc | RCMT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $32.05 | $227,899,825.95 | 13.32 | 4.67 |
| 347 | Rockwell Medical, Inc. (DE) Common Stock | RMTI | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.73 | $31,155,494.45 | Not reported | 0.89 |
| 348 | RxSight, Inc. Common Stock | RXST | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.54 | $190,358,667.88 | Not reported | 0.75 |
| 349 | SBC Medical Group Holdings Incorporated Common Stock | SBC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.04 | $518,348,592.72 | 10.57 | 1.85 |
| 350 | Surgery Partners, Inc. Common Stock | SGRY | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $23.2 | $3,037,303,632 | Not reported | Not reported |
| 351 | SI-BONE, Inc. Common Stock | SIBN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $24.24 | $1,093,541,228.88 | Not reported | 5.92 |
| 352 | Sionna Therapeutics, Inc. Common Stock | SION | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.28 | $148,296,668.72 | Not reported | 0.56 |
| 353 | Sun Life Financial Inc. | SLF | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $71.53 | $39,772,513,027.78 | 14.68 | 2.14 |
| 354 | SelectQuote, Inc. | SLQT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.48 | $86,150,217.02 | 1.19 | 0.14 |
| 355 | Solesence, Inc. Common Stock | SLSN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.86 | $60,558,646.97 | Not reported | 4.6 |
| 356 | Sundial Growers Inc. Common Shares | SNDL | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.42 | $346,359,092.76 | Not reported | 0.43 |
| 357 | SANUWAVE Health, Inc. Common Stock | SNWV | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.19 | $18,839,056.71 | 1.32 | 6.76 |
| 358 | Solventum Corporation | SOLV | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $90.38 | $15,341,041,097.3 | 98.34 | 3.19 |
| 359 | Sensus Healthcare, Inc | SRTS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.86 | $47,081,488.74 | Not reported | 1.28 |
| 360 | Staar Surgical Co | STAA | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.21 | $1,265,587,856.99 | 2,387.9 | 3.36 |
| 361 | Supernus, Inc. Common Stock | SUPN | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $26.16 | $1,523,446,330.56 | 11.16 | 1.43 |
| 362 | Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) | TAK | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $21.02 | $68,797,184,937.82 | Not reported | 1.47 |
| 363 | Tarsus Pharmaceuticals, Inc. Common Stock | TARS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $68.6 | $3,382,360,867.2 | Not reported | 32.51 |
| 364 | Teladoc Health, Inc. | TDOC | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.77 | $1,598,715,529.75 | Not reported | 1.23 |
| 365 | Teva Pharmaceutical Industries Limited | TEVA | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $42.61 | $49,718,489,266.24 | 98.06 | 6.23 |
| 366 | Teleflex Incorporated | TFX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $150.87 | $5,983,694,447.07 | 19.64 | 1.71 |
| 367 | TG Therapeutics, Inc. | TGTX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $59.83 | $9,157,356,095.73 | 20.74 | 15.16 |
| 368 | TRINET GROUP, INC. | TNET | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $66.63 | $3,052,329,628.2 | 17.75 | 22.95 |
| 369 | Trupanion, Inc. | TRUP | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $36.75 | $1,590,023,001 | 59.72 | 3.98 |
| 370 | Telus Corporation | TU | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $9.11 | $14,348,250,000 | 25.78 | 1.19 |
| 371 | Travere Therapeutics, Inc. Common Stock | TVTX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $49.6 | $4,761,210,888 | Not reported | 210.82 |
| 372 | United-Guardian, Inc. | UG | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.71 | $30,827,880.49 | 12.5 | 2.65 |
| 373 | Telefonica Brasil, S.A. American Depositary Shares (each representing two (2) Common Shares) | VIV | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $11.43 | $18,262,890,301.68 | 16.5 | 1.46 |
| 374 | Varex Imaging Corporation Common Stock | VREX | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $18.44 | $776,324,000 | 35.13 | 1.52 |
| 375 | Viatris Inc. Common Stock | VTRS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $19.91 | $22,825,913,654.39 | Not reported | 1.67 |
| 376 | GeneDx Holdings Corp. Class A Common Stock | WGS | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $62.37 | $1,860,031,882.17 | Not reported | 7.62 |
| 377 | Weis Markets, Inc. | WMK | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $77.72 | $1,923,150,078.84 | 18.97 | 1.38 |
| 378 | Petco Health and Wellness Company, Inc. Class A Common Stock | WOOF | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.96 | $959,662,008.48 | 31.7 | 0.8 |
| 379 | Warby Parker Inc. | WRBY | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.48 | $3,149,533,215.92 | 421.57 | 7.81 |
| 380 | Xtant Medical Holdings, Inc. | XTNT | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.29 | $40,599,335.62 | Not reported | 1.01 |
| 381 | Zhibao Technology Inc. Class A Ordinary Shares | ZBAO | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.23 | $118,689.2 | Not reported | 0.03 |
| 382 | JIN MEDICAL INTERNATIONAL LTD. Class A Ordinary Shares | ZJYL | 2.5 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $3.36 | $247,509,118.08 | 207.76 | 8.37 |
| 383 | Zai Lab Limited American Depositary Shares | ZLAB | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.48 | $2,864,773,806.44 | Not reported | 5.09 |
| 384 | Zura Bio Limited Class A Ordinary Shares | ZURA | 2.5 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.09 | $393,970,930.99 | Not reported | 2.22 |
| 385 | Aardvark Therapeutics, Inc. Common Stock | AARD | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.17 | $25,605,269.82 | Not reported | 0.34 |
| 386 | AbCellera Biologics Inc. Common Shares | ABCL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $11.88 | $3,642,544,216.08 | Not reported | 4.07 |
| 387 | Achieve Life Sciences, Inc. | ACHV | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.72 | $691,504,732.8 | Not reported | Not reported |
| 388 | AC Immune SA | ACIU | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $2.23 | $221,722,058.36 | Not reported | 3.92 |
| 389 | Alpha Cognition Inc. Common Stock | ACOG | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.29 | $180,538,525.72 | Not reported | 3.41 |
| 390 | Aclaris Therapeutics, Inc. | ACRS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.9 | $618,587,381.1 | Not reported | 3.71 |
| 391 | Aegon Ltd. | AEG | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $8.3 | $12,089,828,164.9 | 10.92 | 1.09 |
| 392 | AETHLON MEDICAL INC | AEMD | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.47 | $3,889,913.92 | Not reported | Not reported |
| 393 | Agios Pharmaceuticals, Inc. | AGIO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $29.41 | $1,759,001,835.91 | Not reported | 1.8 |
| 394 | Akso Health Group ADS | AHG | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.35 | $1,156,550,638.5 | Not reported | 6.39 |
| 395 | C3.ai, Inc. | AI | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $11.69 | $1,817,202,048.13 | Not reported | 2.62 |
| 396 | AIFU Inc. Class A Ordinary Share | AIFU | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $7.68 | $45,515,670.39 | Not reported | 0.68 |
| 397 | AirSculpt Technologies, Inc. Common Stock | AIRS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.53 | $39,469,089.8 | Not reported | 0.37 |
| 398 | Altimmune, Inc. Common Stock | ALT | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.08 | $404,596,818.08 | Not reported | 0.85 |
| 399 | Amylyx Pharmaceuticals, Inc. Common Stock | AMLX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $29.5 | $3,792,605,668 | Not reported | 5.03 |
| 400 | Amarin Corp Plc | AMRN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $11.61 | $256,638,385.33 | Not reported | 0.58 |
| 401 | American Shared Hospital Services | AMS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.16 | $7,714,000 | Not reported | 0.3 |
| 402 | AnaptysBio, Inc. Common Stock | ANAB | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $46.45 | $1,388,634,083.8 | Not reported | Not reported |
| 403 | AngioDynamics, Inc. | ANGO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $11.73 | $493,298,698.5 | Not reported | 3.01 |
| 404 | Anika Therapeutics Inc | ANIK | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $14.55 | $194,901,804.15 | Not reported | Not reported |
| 405 | Alto Neuroscience Inc. | ANRO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.16 | $987,331,336.64 | Not reported | 4.5 |
| 406 | Apyx Medical Corporation Common Stock | APYX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.93 | $123,423,387.39 | Not reported | 12.3 |
| 407 | Aquestive Therapeutics, Inc. Common Stock | AQST | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.61 | $453,732,615.05 | Not reported | Not reported |
| 408 | Accuray Incorporated | ARAY | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.11 | $13,138,323.77 | Not reported | 0.32 |
| 409 | Arcturus Therapeutics Holdings Inc. Common Stock | ARCT | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.35 | $298,313,019.9 | Not reported | 1.77 |
| 410 | Arvinas, Inc | ARVN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.41 | $419,758,888.46 | Not reported | 0.82 |
| 411 | Assembly Biosciences, Inc | ASMB | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $20.42 | $415,763,370.32 | Not reported | 1.36 |
| 412 | Ascendis Pharma A/S Ordinary Share | ASND | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $256.82 | $16,899,691,338.44 | Not reported | Not reported |
| 413 | Alphatec Holdings, Inc. | ATEC | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.44 | $1,154,240,290.56 | Not reported | Not reported |
| 414 | Alterity Therapeutics Limited American Depositary Shares | ATHE | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $2.43 | $880,910.89 | Not reported | 0.03 |
| 415 | Atossa Therapeutics, Inc. Common Stock | ATOS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.12 | $21,156,111.76 | Not reported | 0.79 |
| 416 | Atara Biotherapeutics, Inc | ATRA | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.87 | $78,996,777.7 | Not reported | Not reported |
| 417 | Aura Biosciences, Inc. Common Stock | AURA | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.56 | $680,303,547.04 | Not reported | 2.16 |
| 418 | Anavex Life Sciences | AVXL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.15 | $106,601,368.3 | Not reported | 0.95 |
| 419 | Axsome Therapeutics, Inc | AXSM | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $132.37 | $6,962,660,014.45 | Not reported | 66.04 |
| 420 | AYTU BioPharma, Inc. Common Stock | AYTU | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.83 | $19,886,075.64 | Not reported | 0.56 |
| 421 | Baxter International Inc. | BAX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $25.79 | $13,342,409,768.52 | Not reported | 2.06 |
| 422 | Beta Bionics, Inc. Common Stock | BBNX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $15.7 | $853,562,951.9 | Not reported | 2.13 |
| 423 | Brookfield Business Corporation Class A Subordinate Voting Shares | BBUC | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $29.64 | $6,089,301,294.96 | 15.73 | 0.4 |
| 424 | Bicara Therapeutics Inc. Common Stock | BCAX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.65 | $572,395,879.1 | Not reported | 1.22 |
| 425 | Bicycle Therapeutics plc American Depositary Shares | BCYC | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.61 | $252,674,776.93 | Not reported | 0.5 |
| 426 | Black Diamond Therapeutics, Inc. Common Stock | BDTX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.74 | $99,682,251.05 | Not reported | 1.04 |
| 427 | Beam Therapeutics Inc. Common Stock | BEAM | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $26.41 | $2,733,319,958.04 | Not reported | 2.87 |
| 428 | Butterfly Network, Inc. | BFLY | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.37 | $1,696,236,615.71 | Not reported | 9.2 |
| 429 | BGM Group Ltd. Class A Ordinary Shares | BGM | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $8.25 | $110,171,415.75 | Not reported | 0.28 |
| 430 | Bausch Health Companies Inc | BHC | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.18 | $3,061,501,736.88 | Not reported | Not reported |
| 431 | Brookdale Senior Living, Inc. | BKD | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.01 | $2,151,743,440.52 | Not reported | Not reported |
| 432 | BioLineRX Ltd | BLRX | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.71 | $7,440,821.01 | Not reported | 0.32 |
| 433 | Belite Bio, Inc American Depositary Shares | BLTE | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $154.19 | $6,065,828,432.4 | Not reported | 7.87 |
| 434 | Benitec Biopharma Inc. Common Stock | BNTC | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.54 | $332,781,206.04 | Not reported | 1.88 |
| 435 | BioNTech SE American Depositary Share | BNTX | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $87.51 | $21,982,894,068.66 | Not reported | 0.97 |
| 436 | Candel Therapeutics, Inc. Common Stock | CADL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $8.75 | $669,537,443.75 | Not reported | 5.31 |
| 437 | CAMP4 Therapeutics Corporation Common Stock | CAMP | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.06 | $254,782,052 | Not reported | 2.38 |
| 438 | Capricor Therapeutics Inc | CAPR | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $9 | $523,250,901 | Not reported | 2.13 |
| 439 | CeriBell, Inc. Common Stock | CBLL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $26.59 | $1,032,622,915.9 | Not reported | 8.79 |
| 440 | Cryo-Cell International Inc. | CCEL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.89 | $39,426,358.5 | Not reported | Not reported |
| 441 | Cerus Corp | CERS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.02 | $407,947,451.68 | Not reported | 5.34 |
| 442 | Cullinan Therapeutics, Inc. Common Stock | CGEM | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $11.31 | $727,851,589.14 | Not reported | 2.26 |
| 443 | Compugen Ltd | CGEN | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.96 | $185,666,734.96 | 5.25 | 1.81 |
| 444 | Celldex Therapeutics, Inc | CLDX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $29.87 | $2,346,140,673.37 | Not reported | 3.61 |
| 445 | Click Holdings Limited Class A Ordinary Share | CLIK | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.68 | $5,811,730.5 | 3.11 | 0.19 |
| 446 | Cellectis S.A. American Depositary Shares | CLLS | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.07 | $77,403,201.87 | Not reported | 1.02 |
| 447 | Compass Therapeutics, Inc. Common Stock | CMPX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.76 | $136,650,709.9 | Not reported | 0.82 |
| 448 | Conduent Incorporated Common Stock | CNDT | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.42 | $221,068,045.24 | Not reported | 0.36 |
| 449 | Context Therapeutics Inc. Common Stock | CNTX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.19 | $17,778,620.75 | Not reported | 0.47 |
| 450 | Coya Therapeutics, Inc. Common Stock | COYA | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.99 | $70,138,968.51 | Not reported | 1.62 |
| 451 | Cumberland Pharmaceuticals Inc | CPIX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $5.22 | $78,211,818.54 | Not reported | 4.57 |
| 452 | Cardiol Therapeutics Inc. Class A Common Shares | CRDL | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1 | $120,905,380.28 | Not reported | 9.28 |
| 453 | CervoMed Inc. Common Stock | CRVO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.42 | $21,469,116.32 | Not reported | 0.94 |
| 454 | Corvus Pharmaceuticals, Inc. | CRVS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.54 | $889,081,948.04 | Not reported | 4.27 |
| 455 | CytomX Therapeutics, Inc. | CTMX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.19 | $477,430,774.8 | Not reported | 1.68 |
| 456 | Contineum Therapeutics, Inc. Class A Common Stock | CTNM | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.52 | $358,153,176.64 | Not reported | 1.46 |
| 457 | CVRx, Inc. Common Stock | CVRX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.87 | $24,744,936.01 | Not reported | 1.79 |
| 458 | Journey Medical Corporation Common Stock | DERM | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.47 | $126,163,045.65 | Not reported | 3.93 |
| 459 | Diversified Healthcare Trust 6.25% Senior Notes Due 2046 | DHCNL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $19.92 | $4,831,180,807.44 | Not reported | 3.16 |
| 460 | DiaMedica Therapeutics Inc. Common Stock | DMAC | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.36 | $504,744,523.92 | Not reported | 13.17 |
| 461 | Dianthus Therapeutics, Inc. Common Stock | DNTH | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $86.03 | $4,844,582,613.36 | Not reported | 3.9 |
| 462 | DarioHealth Corp. Common Stock | DRIO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.38 | $23,273,767.38 | Not reported | 0.42 |
| 463 | Bright Minds Biosciences Inc. Common Stock | DRUG | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $23 | $226,873,403 | Not reported | 3.85 |
| 464 | Design Therapeutics, Inc. Common Stock | DSGN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $10.21 | $653,810,418.8 | Not reported | 3.23 |
| 465 | Dyne Therapeutics, Inc. Common Stock | DYN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $18.07 | $3,386,082,421.41 | Not reported | 3.64 |
| 466 | Emergent Biosolutions, Inc. | EBS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $6.06 | $311,576,002.92 | Not reported | 0.99 |
| 467 | electroCore, Inc. Common Stock | ECOR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $7.25 | $66,888,543.5 | Not reported | Not reported |
| 468 | Edesa Biotech, Inc. Common Shares | EDSA | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.14 | $20,631,806.34 | Not reported | Not reported |
| 469 | eHealth, Inc. | EHTH | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.47 | $15,337,922.36 | 0.67 | 0.02 |
| 470 | Eledon Pharmaceuticals, Inc. Common Stock | ELDN | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $2.61 | $211,685,300.96 | Not reported | 2.94 |
| 471 | Enovis Corporation | ENOV | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $27.16 | $1,566,990,930.96 | Not reported | 1.05 |
| 472 | Enanta Pharmaceuticals, Inc | ENTA | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $11 | $320,379,422 | Not reported | 3.17 |
| 473 | Entera Bio Ltd. Ordinary Shares | ENTX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.14 | $154,771,331.62 | Not reported | 21.3 |
| 474 | Equillium, Inc. Common Stock | EQ | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.51 | $95,746,203.82 | Not reported | 1.71 |
| 475 | Erasca, Inc. Common Stock | ERAS | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $14.41 | $5,040,070,924.35 | Not reported | 13.93 |
| 476 | EVOGENE LTD. | EVGN | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $0.27 | $3,681,943.4 | Not reported | 0.31 |
| 477 | Evolent Health, Inc Class A Common Stock | EVH | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.58 | $518,023,277.02 | Not reported | 1.39 |
| 478 | Evommune, Inc. | EVMN | 2 | 2026-10-15 | 2026 IPO | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $6.65 | $241,342,551.45 | Not reported | 0.87 |
| 479 | Evotec SE American Depositary Shares | EVO | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.69 | $600,892,705.66 | Not reported | Not reported |
| 480 | Edgewise Therapeutics, Inc. Common Stock | EWTX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $45.04 | $4,931,103,645.52 | 4.88 | 3.02 |
| 481 | EyePoint, Inc. Common Stock | EYPT | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.36 | $31,036,369.68 | Not reported | 0.19 |
| 482 | Fortress Biotech, Inc. | FBIO | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.85 | $61,625,372.2 | 0.55 | 0.3 |
| 483 | Fennec Pharmaceuticals Inc. Common Stock | FENC | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $9.81 | $344,008,829.79 | Not reported | 8.11 |
| 484 | Fortrea Holdings Inc. Common Stock | FTRE | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $21.96 | $2,119,140,000 | Not reported | 3.98 |
| 485 | Fulcrum Therapeutics, Inc. Common Stock | FULC | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $3.7 | $282,299,850.9 | Not reported | 0.91 |
| 486 | Gain Therapeutics, Inc. Common Stock | GANX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.03 | $44,952,927.57 | Not reported | 3.98 |
| 487 | Guardant Health, Inc. Common Stock | GH | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $150.87 | $20,410,595,048.25 | Not reported | Not reported |
| 488 | GH Research PLC Ordinary Shares | GHRS | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $18.61 | $1,277,432,961.07 | Not reported | 4.57 |
| 489 | Genmab A/S ADS | GMAB | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $53.63 | $3,445,105,821.04 | 3.58 | 0.59 |
| 490 | Structure Therapeutics Inc. American Depositary Shares | GPCR | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $20.35 | $1,451,155,596.73 | Not reported | 1.07 |
| 491 | GRAIL, Inc. Common Stock | GRAL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $121.44 | $5,460,206,046.24 | Not reported | 2.23 |
| 492 | Grace Therapeutics, Inc. Common Stock | GRCE | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $1.85 | $38,916,470.5 | Not reported | 0.81 |
| 493 | Helen Of Troy Ltd | HELE | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $37.43 | $875,511,468.05 | Not reported | 1.03 |
| 494 | Cellyan Biotechnology Co., Ltd Class A Ordinary Shares | HKPD | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $1.45 | $3,575,515.85 | Not reported | 0.37 |
| 495 | Harrow, Inc. Common Stock | HROW | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $26.89 | $1,008,048,286.5 | Not reported | 67.9 |
| 496 | Heron Therapeutics, Inc. | HRTX | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $0.29 | $55,626,725.95 | Not reported | 8.05 |
| 497 | Heartflow, Inc. Common Stock | HTFL | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $52.4 | $4,556,370,054.8 | Not reported | 16.29 |
| 498 | Huize Holding Limited American Depositary Shares | HUIZ | 2 | 2025-12-31 | 2025 FY | openrouter::anthropic/claude-haiku-5.5 | 2026-11-06 | $2.28 | $23,041,853.8 | 39.86 | 0.37 |
| 499 | IDEAYA Biosciences, Inc. Common Stock | IDYA | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $31.24 | $3,020,738,523 | Not reported | 2.77 |
| 500 | Icahn Enterprises L.P | IEP | 2 | 2025-12-31 | 2025 FY | anthropic/claude-haiku-5-5 | 2026-11-06 | $4.75 | $3,595,566,061 | Not reported | 2.3 |
No matching rows. Clear the filter to see all records.
Top 500 of 1071 companies with eligible ratings and dated fundamentals. This selection contains 1108 companies.
Inspect the highest-rated company
Ratings and dated fundamentals
Healthcare: source evidence dated 2026-11-07T12:42:51.530Z.
- Rank
- 1
- Company
- ResMed Inc.
- Ticker
- RMD
- Rating / 5
- 4.5
- Report date
- 2025-12-31
- Fiscal period
- 2025 FY
- Model
- anthropic/claude-haiku-5-5
- Market day
- 2026-11-06
The selected ticker, rating, report date and producing model match the first displayed row. Equal ratings use ticker order.
Which company leads this published industry selection?
The first row is highest by the stored 1-to-5 report rating, not forecast return. Check its report date, fiscal period and model.
NexusTrade stock ratings and report filters- Median market capitalization
- $3,063,209,786.4 · 500 / 500 displayed companies
- Median positive P/E (TTM)
- 22.23 · 313 / 500 displayed companies
- Median positive price / book
- 2.43 · 439 / 500 displayed companies
- Largest company by market cap
- Alphabet Inc. Class A Common Stock (GOOGL) · $3,501,085,320,000
- Largest company's share of displayed market cap
- 13.61% · Sum of displayed market caps; not portfolio weights or revenue exposure
Check each median’s included count and each company’s market date. These are unweighted summaries of displayed companies, not a sector index or revenue exposure.
Open this industry in the stock screener
Read the company's fundamentals and compare another dated report before treating equal ratings as equal businesses.
Open this industry in the stock screenerKeep reporting dates and units beside the answer, and inspect its original citations.
How is this ranking built?

Every industry list applies the same steps at its own cutoff: industry membership, the latest AI report rating on or before the cutoff, a report age limit, dated market data, then a sort by rating with ties ordered by ticker. The animation steps through them with one real example, the live cybersecurity list refreshed on October 13, 2026.
A live list's cutoff is its refresh time. A past year's list uses December 31 of the year before, and the current year's list uses the time it was generated. A Top N page shows the first N rows of its year's list and exists only when that list has at least N companies.
What best means in this list
This list was refreshed on 2026-11-07 using existing company reports. The report date in each row is the date of the underlying analysis; refreshing the list does not create a new company report.
Best means the highest stored NexusTrade report ratings within this selection. Ratings use the product's 1-to-5 scale. The list sorts by rating from high to low, with ticker order breaking equal-rating ties. A rating summarizes a report; it does not predict a stock's return.
Companies belong to the Healthcare classification, based on company products and revenue. Classifications can overlap, so a company may appear in several industry lists.
What the leading companies do
The first 5 companies below lead the ratings in this snapshot; equal ratings are ordered by ticker. Their company profiles describe different businesses even when they share the Healthcare selection.
These are company descriptions, not estimates of revenue from this theme. Industry membership does not identify a pure-play business or establish how much sales depend on it. Open the company profile and examine segment disclosures before treating an overlapping classification as equivalent exposure.
ResMed Inc. (RMD): 4.5 / 5
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications to diagnose, treat, and manage respiratory disorders in the United States and internationally. The company operates in two segments, Sleep and Breathing Health, and Residential Care Software. It offers sleep recorders for the diagnosis and titration of sleep apnea in sleep clinics, hospitals, and at home, including ApneaLink Air, a portable diagnostic device that measures oximetry, respiratory effort, pulse, nasal flow, and snoring; NightOwl, a portable, cloud-connected, and disposable diagnostic device that measures AHI based on derived peripheral arterial tone, actigraphy, and oximetry; and EasyCare Tx, a sleep lab solution. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; and connectivity module which provides a cellular connection between compatible ventilation devices and AirView system. In addition, the company offers Brightree solutions which are solutions and services for organizations in home medical equipment and pharmacy, orthotic and prosthetic, and home infusion; HEALTHCAREfirst solutions that offers electronic health record, software, billing and coding services, and advanced analytics that enables home health and hospice agencies to optimize clinical, financial and administrative processes; MatrixCare EHR software as a service solutions used by skilled nursing and senior living providers, life plan communities, and home health and hospice sectors; and MEDIFOX DAN software solutions that is used by residential care providers, such as home health and nursing home providers. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.
Arch Capital Group Ltd (ACGL): 4 / 5
Arch Capital Group Ltd., together with its subsidiaries, provides insurance, reinsurance, and mortgage insurance products in the United States, Canada, Bermuda, the United Kingdom, Europe, and Australia. The Insurance segment offers commercial automobile; commercial multiperil; financial and professional line liability; admitted, excess, and surplus casualty lines; property and short-tail specialty; workers compensation; casualty; marine and aviation; excess and surplus casualty; construction and national accounts; alternative market risks and employer's liability; travel, accident, and health; contract and commercial surety coverage; and other insurance products, as well as Lloyd's syndicates; programs; and warranty and lenders solutions. Its Reinsurance segment provides reinsurance products for casualty; marine and aviation; property catastrophe; property excluding property catastrophe; and other specialty products. The Mortgage segment offers U.S. primary mortgage insurance business written predominantly on loans sold to the Federal National Mortgage Association and Federal Home Loan Mortgage Corporation; reinsurance and underwriting services related to the U.S. credit-risk transfer business and other U.S. mortgage reinsurance transactions; and international mortgage insurance and reinsurance business covering loans. It markets its products through a group of licensed independent retail and wholesale brokers. The company was formerly known as Risk Capital Holdings, Inc. Arch Capital Group Ltd. was founded in 1995 and is headquartered in Pembroke, Bermuda.
Addus HomeCare Corp. (ADUS): 4 / 5
Addus HomeCare Corporation, together with its subsidiaries, provides personal care services to elderly, chronically ill, disabled persons, and individuals who are at risk of hospitalization or institutionalization in the United States. It operates through three segments: Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living. This segment offers services that include assistance with bathing, grooming, oral care, feeding and dressing, medication reminders, meal planning and preparation, housekeeping, and transportation services. The Hospice segment provides palliative nursing care, social work, spiritual counseling, homemaker, and bereavement counseling services for people who are terminally ill, as well as related services for their families. The Home Health segment offers skilled nursing and physical, occupational, and speech therapy for the individuals who requires assistance during an illness or after hospitalization. The company serves federal, state, and local governmental agencies; managed care organizations; commercial insurers; and private individuals. Addus HomeCare Corporation was founded in 1979 and is headquartered in Frisco, Texas.
Ametek, Inc. (AME): 4 / 5
AMETEK, Inc. manufactures and sells electronic instruments (EIG) and electromechanical (EMG) devices in the United States and internationally. The company's EIG segment offers advanced instruments for the process, aerospace, power, and industrial markets; process and analytical instruments for the oil and gas, petrochemical, pharmaceutical, semiconductor, automation, and food and beverage industries; instruments to the laboratory equipment, ultra-precision manufacturing, medical, and test and measurement markets; power quality monitoring and metering devices, uninterruptible power supplies, programmable power and electromagnetic compatibility test equipment, and gas turbines sensors; dashboard instruments for heavy trucks and other vehicles; instrumentation and controls for the food and beverage industries; and aircraft and engine sensors, power supplies, embedded computing, monitoring, fuel and fluid measurement, and data acquisition systems for aerospace and defense industry. Its EMG segment offers engineered medical components and devices, automation solutions, thermal management systems, specialty metals, and electrical interconnects; single-use and consumable surgical instruments, implantable components, and drug delivery systems; engineered electrical connectors and electronics packaging to protect sensitive electronic devices; precision motion control products for data storage, medical devices, business equipment, and automation; high-purity powdered metals, strips and foils, specialty clad metals, and metal matrix composites; motor-blower systems and heat exchangers for thermal management, military and commercial aircraft, and military ground vehicles; and motors for commercial appliances, food and beverage machines, hydraulic pumps, and industrial blowers, as well as operates a network of aviation maintenance, repair, and overhaul facilities. AMETEK, Inc. was incorporated in 1930 and is headquartered in Berwyn, Pennsylvania.
Brown & Brown, Inc. (BRO): 4 / 5
Brown & Brown, Inc. markets and sells insurance products and services in the United States, Canada, Ireland, the United Kingdom, and internationally. It operates through four segments: Retail, Programs, Wholesale Brokerage, and Services. The Retail segment provides property and casualty, employee benefits insurance products, personal insurance products, specialties insurance products, risk management strategies, loss control survey and analysis, consultancy, and claims processing services. It serves commercial, public and quasi-public entities, professional, and individual customers. The Programs segment offers professional liability and related package insurance products for dentistry, legal, eyecare, insurance, financial, physicians, real estate title professionals, as well as supplementary insurance products related to weddings, events, medical facilities, and cyber liabilities. This segment also provides public entity-related and specialty programs through a network of independent agents; and program management services for insurance carrier partners. The Wholesale Brokerage segment markets and sells excess and surplus commercial and personal lines insurance through independent agents and brokers. The Services segment offers third-party claims administration and medical utilization management services in the workers' compensation and all-lines liability arenas, Medicare Set-aside, Social Security disability, Medicare benefits advocacy, and claims adjusting services. Brown & Brown, Inc. was founded in 1939 and is headquartered in Daytona Beach, Florida.
Valuation and company size within this selection
These summaries use the 500 displayed companies; the snapshot is truncated, so they do not describe the full industry. Each company retains its own market observation date in the ratings table above. Medians are unweighted; they are not a sector index valuation.
Positive P/E and price-to-book values are summarized separately. Missing, zero and negative values are excluded from those medians, with the included count shown. A lower multiple alone does not establish better value: profitability, growth, debt and business mix can differ.
Show the table · 5 rows, 3 columns
Scroll sideways to compare all columns. Select a heading to sort.
| Median market capitalization | $3,063,209,786.4 | 500 / 500 displayed companies |
| Median positive P/E (TTM) | 22.23 | 313 / 500 displayed companies |
| Median positive price / book | 2.43 | 439 / 500 displayed companies |
| Largest company by market cap | Alphabet Inc. Class A Common Stock (GOOGL) | $3,501,085,320,000 |
| Largest company's share of displayed market cap | 13.61% | Sum of displayed market caps; not portfolio weights or revenue exposure |
No matching rows. Clear the filter to see all records.
Other business classifications in the list
A company can appear in several product and revenue classifications. These overlapping memberships help identify different business mixes to investigate; they are not verified revenue shares or mutually exclusive subindustries.
Show the table · 5 rows, 2 columns
| Additional classification | Matching displayed companies |
|---|---|
| Pharmaceuticals | 219 / 500 |
| Manufacturing | 210 / 500 |
| Technology | 179 / 500 |
| Biotechnology | 165 / 500 |
| Medical Devices | 157 / 500 |
No matching rows. Clear the filter to see all records.
Dates and coverage
Report dates range from 2025-11-06 to 2026-10-15. Market observations range from 2026-11-05 to 2026-11-06. These dates may differ across companies. Daily closes are not synchronized live quotes.
The selection includes 18 companies without a report, 0 with invalid latest rating metadata, 2 with older reports, 17 with missing required fundamentals and 0 with out-of-date market observations. Missing companies receive no substitute score.
How the ranking is built
The ranking uses the latest stored report at or before the refresh cutoff for each active eligible company. The report date, fiscal year/period and producing model remain visible. The latest invalid score is excluded; an older favorable score does not replace it. Publication policy stock-ratings-v1 accepts report ages up to 550 days and market observations up to 10 calendar days, with a positive close and market capitalization. Optional missing ratios remain not reported.
Report ages can differ substantially, particularly between annual and quarterly reports. Different producing models may also use different judgments. Read the date, fiscal period and model before comparing scores. Private report analysis and account data are not published here.
A refresh reads existing reports and market data. It does not rerun a model or create a new analysis. Compare business fundamentals and your own research constraints alongside the score before making a decision.